{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:47:35Z","timestamp":1783687655583,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejrad.2021.110100","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T18:41:11Z","timestamp":1639248071000},"page":"110100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Enhanced computed tomography features predict pancreatic neuroendocrine neoplasm with Ki-67 index less than 5%"],"prefix":"10.1016","volume":"147","author":[{"given":"Haopeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejrad.2021.110100_b0005","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1210\/jc.2003-031575","article-title":"Non-islet origin of pancreatic islet cell tumors","volume":"89","author":"Vortmeyer","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110100_b0010","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/s41467-018-06498-2","article-title":"ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup","volume":"9","author":"Chan","year":"2018","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110100_b0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000494258","article-title":"Unmet needs in functional and nonfunctional pancreatic neuroendocrine neoplasms","volume":"108","author":"Jensen","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.ejrad.2021.110100_b0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/SLA.0b013e31815b9cae","article-title":"Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients","volume":"247","author":"Bilimoria","year":"2008","journal-title":"Ann Surg."},{"issue":"10","key":"10.1016\/j.ejrad.2021.110100_b0025","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/annonc\/mdn351","article-title":"Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival","volume":"19","author":"Halfdanarson","year":"2008","journal-title":"Ann Oncol."},{"issue":"5","key":"10.1016\/j.ejrad.2021.110100_b0030","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1530\/ERC-12-0024","article-title":"Neuroendocrine tumor disease: an evolving landscape","volume":"19","author":"Frilling","year":"2012","journal-title":"Endocr Relat Cancer."},{"issue":"18","key":"10.1016\/j.ejrad.2021.110100_b0035","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110100_b0040","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1677\/ERC-10-0152","article-title":"Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters","volume":"17","author":"Niederle","year":"2010","journal-title":"Endocr Relat Cancer."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110100_b0045","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J Immunol."},{"issue":"2","key":"10.1016\/j.ejrad.2021.110100_b0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: more than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"issue":"6","key":"10.1016\/j.ejrad.2021.110100_b0055","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.ejrad.2021.110100_b0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/his.13408","article-title":"Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases","volume":"72","author":"Singhi","year":"2018","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.ejrad.2021.110100_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12022-013-9295-2","article-title":"Neuroendocrine tumors of the pancreas: current concepts and controversies","volume":"25","author":"Reid","year":"2014","journal-title":"Endocr Pathol."},{"key":"10.1016\/j.ejrad.2021.110100_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pan.2016.02.002","article-title":"Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours","author":"Ricci","year":"2016","journal-title":"Pancreatology."},{"issue":"5","key":"10.1016\/j.ejrad.2021.110100_b0075","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ijc.27543","article-title":"Pancreatic neuroendocrine tumors: a comprehensive review","volume":"131","author":"Zhou","year":"2012","journal-title":"Int J Cancer."},{"issue":"2","key":"10.1016\/j.ejrad.2021.110100_b0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2214\/AJR.17.18417","article-title":"Prediction of pancreatic neuroendocrine tumor grade based on CT features and texture analysis","volume":"210","author":"Canellas","year":"2018","journal-title":"Am J Roentgenol."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110100_b0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/0284185117725367","article-title":"Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis","volume":"59","author":"Choi","year":"2018","journal-title":"Acta Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2021.110100_b0090","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/s41598-018-38459-6","article-title":"CT enhancement and 3D texture analysis of pancreatic neuroendocrine neoplasms","volume":"9","author":"D'Onofrio","year":"2019","journal-title":"Sci Rep."},{"issue":"12","key":"10.1016\/j.ejrad.2021.110100_b0095","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1007\/s00330-019-06176-x","article-title":"CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study","volume":"29","author":"Gu","year":"2019","journal-title":"Eur Rad."},{"key":"10.1016\/j.ejrad.2021.110100_b0100","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/jgh.14139","article-title":"Association between pathologic grade and multiphase computed tomography enhancement in pancreatic neuroendocrine neoplasm","volume":"33","author":"Kang","year":"2018","journal-title":"J Gastroenterol Hepatol."},{"issue":"5","key":"10.1016\/j.ejrad.2021.110100_b0105","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00330-014-3532-z","article-title":"Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1\/2 neuroendocrine tumour","volume":"25","author":"Kim","year":"2015","journal-title":"Eur Rad."},{"issue":"8","key":"10.1016\/j.ejrad.2021.110100_b0110","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ejrad.2015.05.005","article-title":"Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade","volume":"84","author":"Takumi","year":"2015","journal-title":"Eur J Rad."},{"issue":"2","key":"10.1016\/j.ejrad.2021.110100_b0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS Consensus Guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.ejrad.2021.110100_b0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000335587","article-title":"ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors","volume":"95","author":"Falconi","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"10","key":"10.1016\/j.ejrad.2021.110100_b0125","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jnci\/djs208","article-title":"TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study","volume":"104","author":"Rindi","year":"2012","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"10.1016\/j.ejrad.2021.110100_b0130","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/modpathol.2010.58","article-title":"Pancreatic endocrine tumors: Improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients","volume":"23","author":"Scarpa","year":"2010","journal-title":"Mod Pathol."},{"issue":"11","key":"10.1016\/j.ejrad.2021.110100_b0135","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0046-8177(96)90303-2","volume":"27","author":"Pelosi","year":"1996","journal-title":"Hum Pathol."},{"issue":"8","key":"10.1016\/j.ejrad.2021.110100_b0140","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1245\/s10434-018-6518-2","article-title":"Recurrence of pancreatic neuroendocrine tumors and survival predicted by Ki-67","volume":"25","author":"Gen\u00e7","year":"2018","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2021.110100_b0145","first-page":"471","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"68","author":"Cives","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.ejrad.2021.110100_b0150","series-title":"Neuroendocrine and Adrenal Tumors 2020 Version 2","article-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae)","author":"Shah","year":"2020"},{"issue":"4","key":"10.1016\/j.ejrad.2021.110100_b0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q","article-title":"Benign conditions associated with raised serum CA-125 concentration","volume":"75","author":"Buamah","year":"2000","journal-title":"J Surg Oncol."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110100_b0160","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s13277-013-0904-y","article-title":"Alpha-fetoprotein: a renaissance","volume":"34","author":"Terentiev","year":"2013","journal-title":"Tumour Biol."},{"issue":"6","key":"10.1016\/j.ejrad.2021.110100_b0165","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.hbpd.2019.03.009","article-title":"Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors","volume":"18","author":"Li","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int."},{"issue":"5","key":"10.1016\/j.ejrad.2021.110100_b0170","first-page":"242","article-title":"Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?","volume":"35","author":"Toshima","year":"2017","journal-title":"Jpn J Rad."},{"issue":"2","key":"10.1016\/j.ejrad.2021.110100_b0175","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00261-018-1763-1","article-title":"Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade","volume":"44","author":"Guo","year":"2019","journal-title":"Abdom Rad (New York)."},{"issue":"9","key":"10.1016\/j.ejrad.2021.110100_b0180","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1007\/s00330-020-06867-w","article-title":"Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT","volume":"30","author":"Park","year":"2020","journal-title":"Eur Rad."},{"issue":"4","key":"10.1016\/j.ejrad.2021.110100_b0185","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0016-5085(03)01198-3","article-title":"Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors","volume":"125","author":"Marion-Audibert","year":"2003","journal-title":"Gastroenterology"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X21005817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X21005817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:25:25Z","timestamp":1759994725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X21005817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":37,"alternative-id":["S0720048X21005817"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2021.110100","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced computed tomography features predict pancreatic neuroendocrine neoplasm with Ki-67 index less than 5%","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2021.110100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110100"}}